Results 61 to 70 of about 244,568 (170)

Production of n-propyl acetate by reactive distillation : experimental and theoretical study [PDF]

, 2007
First steps of the development of a catalytic reactive distillation process for the production of n-propyl acetate based on experiments and simulations are proposed.
Forner, Florian, Repke, Jens Uwe, Rouzineau, David, Wozny, G, Meyer, Xuân-Mi, Meyer, Michel, Brehelin, Mathias   +6 more
core   +1 more source

Dydrogesterone and Letrozole Combination for the Treatment of Endometriosis: A Mechanism‐Based Therapeutic Approach

Obstetrics and Gynecology International, Volume 2026, Issue 1, 2026.
Endometriosis is a complex, estrogen‐dependent disease with limited effective treatments that often focus on symptom management rather than addressing the underlying pathology. Current therapies, such as progestins and GnRH agonists, have significant side effects (weight gain, mood changes, decreased bone mineral density, and menopausal symptoms) and ...
Santosh Kumar Rai, Rakesh Kumar, Mohd Imran Khan, Anil Kumar, Manvinder Singh   +4 more
wiley   +1 more source

Uterine “twisting sign”: A new potential ultrasonographic soft marker for deep endometriosis

International Journal of Gynecology &Obstetrics, Volume 171, Issue 3, Page 1355-1363, December 2025.
Abstract Objective The objective of the current study was to evaluate the “twisting sign,” defined as uterine fundus rotation observed on transvaginal sonography (TVS), as a potential soft marker for deep endometriosis (DE) and its association with specific DE localizations and indirect signs.
Fabio Barra, Simone Ferrero, Umberto Perrone, Giulio Evangelisti, Alessandra Pulliero, Alberto Izzotti, Umberto Leone Roberti Maggiore, Stefano Bogliolo   +7 more
wiley   +1 more source

The influence of norethindrone and mestranol on pituitary–adrenal function

, 1968
Female Wistar rats were force-fed either Ortho-Novum (66 μg norethindrone and 1 μg mestranol), norethindrone (66 μg), mestranol (1 μg), or water daily for 1 month.
David R. Usher
core   +1 more source

A combination of norethindrone acetate and leuprolide acetate blocks the gonadotrophin-releasing hormone agonistic response and minimizes cyst formation during ovarian stimulation [PDF]

, 1996
A protocol utilizing both leuprolide acetate (LA) and norethindrone acetate (NETA) in subjects undergoing ovarian suppression prior to follicle aspiration proved more effective than LA alone in reducing the incidence of ovarian cyst formation without ...
Sauer, Mark V., Ditkoff, Edward C.
core   +1 more source

Abstracts

Molecular Oncology, Volume 20, Issue S1, Page 1-692, August 2026.
Abstracts submitted to the ‘EACR 2026 Congress: Innovative Cancer Science’, from 08–11 June 2026 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley   +1 more source

Medical treatment of fibroids: FIGO best practice guidance

International Journal of Gynecology &Obstetrics, Volume 171, Issue 2, Page 507-512, November 2025.
Abstract Even though uterine fibroids are a widespread condition, the range of approved medical treatment options remains limited. In fact, only a few drugs are officially approved for the therapy of fibroids. In both the USA and the European Medicines Agency region, selected gonadotropin‐releasing hormone (GnRH) antagonists have been approved for this
Ivonne Diaz, Mary Ann Lumsden, Magdalena Zeppernick   +2 more
wiley   +1 more source

A Comparative Metabolomics Study of the Potential Marker Compounds in Feces from Different Hybrid Offspring of Huainan Pigs

Animals
As a notable native Chinese genetic population, the Huainan pig has an exceptional meat quality but a low percentage of lean meat and subpar genetic performance.
Yufu Li, Mingyang Jia, Junfeng Chen, Fujiu Liu, Qiaoling Ren, Xiangzhou Yan, Baosong Xing, Chuanying Pan, Jing Wang   +8 more
doaj   +1 more source

Safety and efficacy of relugolix combination therapy in symptomatic uterine fibroids

Facts, Views & Vision in ObGyn
Background: Relugolix-combination therapy (CT) (oestradiol 1 mg and norethindrone acetate 0.5 mg) is a new gonadotropin-releasing hormone antagonist licensed to treat heavy menstrual bleeding (HMB) associated with uterine fibroids; but little real-world ...
Maria Chiara De Angelis, Fedora Ambrosetti, Sabrina Reppuccia, Fabiola Nardelli, Brunella Zizolfi, Antonella Mercurio, Antonio Maiorana, Attilio Di Spiezio Sardo   +7 more
doaj   +1 more source

Impact of demographic and clinical factors on elagolix plus add-back therapy effects on patient-reported nonbleeding symptoms in women with heavy menstrual bleeding and uterine fibroids: a post hoc analysis of data from two clinical trials

F&S Reports
Objective: To investigate the efficacy of elagolix plus add-back therapy (estradiol [1 mg] and norethindrone acetate [0.5 mg] once daily) on patient-reported nonbleeding symptoms and menstrual bleeding associated with uterine fibroids (UFs) across ...
James A. Simon, M.D., Elizabeth A. Stewart, M.D., Susan Jewell, Ph.D., Moming Li, Ph.D., Michael C. Snabes, M.D., Ph.D.   +4 more
doaj   +1 more source